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Introduction {#sec1}
============

Recombinant DNA technology in *Escherichia coli* (*E*. *coli*) has been greatly boosted by bacteriophage-encoded recombination systems ([@bib41], [@bib70], [@bib71]). A decisive advantage of this technology, termed recombinogenic engineering or recombineering, is the easy incorporation of the flanking short homology sequences required for homologous recombination into synthetic oligonucleotides. Oligonucleotides and linear dsDNAs with homology arms as short as 35 nucleotides have been exploited in many ways for point mutations, deletions, insertions, and subcloning with base pair precision regardless of the size of the target DNA ([@bib38], [@bib41], [@bib70], [@bib71]).

In *E*. *coli*, recombineering utilizes the Redα, Redβ, and Redγ proteins from the *lambda* phage Red operon or RecE and RecT from the Rac prophage ([@bib21], [@bib70]). Redα and RecE are 5′-3′ exonucleases that generate single-stranded DNA (ssDNA) intermediates ([@bib33]). Redβ and RecT are single-stranded DNA-annealing proteins (SSAPs) that bind to ssDNA to promote the search for the complementary sequence ([@bib19]). The Redα/Redβ and RecE/RecT phage pairs each include a specific protein-protein interaction, which is required for double-stranded DNA (dsDNA) homologous recombination ([@bib40]).

Redγ forms a dimer to mimic DNA that binds to and inhibits the exonuclease and helicase activities of the RecBCD complex ([@bib12], [@bib39]), which aggressively degrades linear dsDNA ([@bib12], [@bib60]). The RecET operon does not appear to have a Redγ equivalent. However, the inclusion of Redγ with RecE/RecT increases homologous recombination efficiency via increased persistence of the linear dsDNA substrates ([@bib21], [@bib70]). The significance of a RecBCD inhibitor for homologous recombination efficiency was also demonstrated in our study describing *Photorhabdus luminescens* Pluγ for the development of a recombineering system for *Photorhabdus* and *Xenorhabdus*. We found that Pluγ could inhibit the RecBCD complex in both *Photorhabdus* and *E*. *coli* ([@bib67]).

The Red system has been applied to precisely and fluently edit the genome of not only *E*. *coli* but also closely related bacteria *Salmonella enterica* ([@bib7]), *Yersinia pseudotuberculosis* ([@bib13]), *Shigella* ([@bib5]), *Serratia* ([@bib49]), and *Escherichia albertii* ([@bib16]). However, its wider application has been limited by apparent host specificities ([@bib67]). Consequently endogenous SSAPs alone or together with partner exonucleases have been used for oligo repair or cassette insertion in *Mycobacterium tuberculosis* ([@bib59]), *Lactococcus lactis* ([@bib44]), *Lactococcus reuteri* ([@bib45]), *Clostridium acetobutylicum* ([@bib15]), *Lactobacillus plantarum* ([@bib64]), *Bacillus subtilis* ([@bib55]), *P. luminescens,* and *Xenorhabdus stockiae* ([@bib67]).

*Pseudomonas* is a gram-negative, aerobic rod that belongs to the bacterial family Pseudomonadaceae ([@bib20]). The best characterized species include the opportunistic human pathogen *Pseudomonas aeruginosa* ([@bib54]), the plant pathogen *Pseudomonas syringae* ([@bib63]), the plant growth-promoting *Pseudomonas fluorescens* ([@bib43]), and the soil bacterium *Pseudomonas putida*, which is used in bioremediation ([@bib23]) and biocontrol ([@bib58]). The members of this genus demonstrate a great deal of metabolic diversity ([@bib1]).

Here, we report the development of recombineering systems for *Pseudomonas* based on two host-specific phage protein-encoding operons from *P*. *aeruginosa* phage Ab31 and *P*. *syringae*. BLAST analysis suggested that Orf38, Orf37, and Orf36 are analogs of Redβ, Redα, and single-stranded DNA-binding protein (SSB), respectively. Recombineering experiments indicated that Redγ or Pluγ worked in some *Pseudomonas* species and SSB significantly increased efficiency. SSBs are often found in recombinase-encoding operons from various phages ([@bib57]). Because proteins in the same operon are usually functionally associated, we were particularly interested in evaluating the contribution of orf36/S to phage recombinase-mediated homologous recombination. Using these systems, we efficiently modified *Pseudomonas* genomes including gene deletions and insertions. In particular, a highly attenuated rhamnolipid producer was obtained after deleting pathogenic factors and overexpressing *rhl*AB and *est*A in *P*. *aeruginosa*.

Results {#sec2}
=======

Endogenous Phage exo/SSAP Protein Pairs in *Pseudomonas* {#sec2.1}
--------------------------------------------------------

We looked for candidate DNA recombination proteins in *Pseudomonas* and *Pseudomonas* phage genomes with BLAST using the coding sequences of λ Redβ, *rac* RecT, or Pluβ as queries in a non-redundant protein sequence database. Two operons including an exonuclease (exo) and SSAP were identified. One was RecTE~Psy~ from *P*. *syringae*, which was previously developed as a recombineering system for use in *P*. *syringae* ([@bib56]). The second operon, from *P*. *aeruginosa* phage vB_PaeP_Tr60_Ab31, encoded three proteins including a candidate SSAP (orf38, here named *B*) that was 62% identical to Redβ over its 177-amino acid sequence ([Figure 1](#fig1){ref-type="fig"}) and was adjacent to a candidate exonuclease (orf37, here named *A*; [Figure 1](#fig1){ref-type="fig"}), which showed significant similarity to Redα (sequence identity of 32% in a 195-amino acid region). The next coding region, orf36 (here named *S*), showed significant similarity to SSBs (sequence identity of 54% across 148 amino acids of the *E*. *coli* SSB; [Figure 1](#fig1){ref-type="fig"}). SSBs are often found in recombinase-encoding operons from various phages ([@bib57]). Because proteins in the same operon are usually functionally associated, we evaluated the contribution of orf36/S to phage recombinase-mediated homologous recombination and we named this candidate recombineering operon, *BAS*.Figure 1Operon Architecture of Lambda Red and *Pseudomonas* Phage vB_PaeP_Tr60_Ab31 orf36-orf38 Orf38, Orf37, and Orf36 Are Related to Redβ (beta), Redα (alpha), and SSB, RespectivelyThe amino acid sequences were compared via ClustalW alignment ([Figure S1](#mmc1){ref-type="supplementary-material"}). The percent identities are displayed between the homology regions.

In gram-negative bacteria, RecBCD, which is the major exonuclease in *E*. *coli*, is highly conserved ([Table S5](#mmc1){ref-type="supplementary-material"}). Notably neither RecTE~Psy~ nor BAS operons contained a homolog of Redγ or Pluγ, which are inhibitors of RecBCD exonuclease activity. Because co-expression of Redγ with Redβα or RecET significantly increases recombineering efficiency ([@bib21]), the addition of Redγ or Pluγ to the RecTE~Psy~ and BAS operons were tested for their abilities to increase recombineering efficiency.

Critical Time Points for Electroporation of *Pseudomonas* {#sec2.2}
---------------------------------------------------------

In *E*. *coli*, transformation efficiency determines optimal recombineering ([@bib51]). When *E*. *coli* DH10B-derived cells are used, the recombinant proteins are usually induced when the cells enter log phase growth (OD~600~ = 0.30--0.35). After two cell divisions, at OD~600~ = 0.70--0.80, the electrocompetent cells are prepared ([@bib22]). This principle was also verified by recombineering in *Photorhabdus* ([@bib67]). To optimize protocols for *Pseudomonas*, we first plotted the growth of the four *Pseudomonas* strains at 30°C. Overnight cultures were diluted to OD~600~ ≈ 0.085 to start the growth-monitoring cultures. After approximately 2 h, *P*. *syringae* and *P*. *aeruginosa* cultures entered the log phase and the plasmid pBBR1-Rha-GFP-kan was transformed into electrocompetent cells prepared at different time points ([Figure 2](#fig2){ref-type="fig"}). We found that cells prepared at 4 and 2.5 h, respectively, yielded the most transformants ([Figures 2](#fig2){ref-type="fig"}B and 2D). The same test was performed for *P*. *fluorescens* ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B) and *P. putida* ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Thereby we established the time points for induction and electrocompetent preparation for each strain ([Table S6](#mmc1){ref-type="supplementary-material"}).Figure 2Optimization of Transformation in *P*. *syringeae* and *P*. *aeruginosa*(A) Growth curve of *P*. *syringeae*. The optical density (OD) at 600 nm (OD~600~) was measured from a starting OD~600~ of 0.085.(B) Time when cells were harvested for electroporation.(C and D) (C) and (D) are the same as (A) and (B), respectively, for *P*. *aeruginosa*. After electroporation of pBBR1-rha-GFP-km, colonies were selected on kanamycin plates and counted.Data represent the mean ± SD from three independent experiments. The statistical analysis used is Student\'s t test. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.

Efficiency of Recombineering Systems in *Pseudomonas* {#sec2.3}
-----------------------------------------------------

We compared the RecTE~Psy~, BAS, Redγβα, and Pluγβα systems in four *Pseudomonas* strains. Pluγ or Redγ was added to the RecTE~Psy~ and BAS operons to generate four more candidate systems: PluγTE~Psy~, RedγTE~Psy~, PluγBAS, and RedγBAS. The eight expression plasmids were transformed into the four *Pseudomonas* strains, followed by plasmid DNA extraction and restriction analysis for confirmation. The expression plasmids were based on a broad host range origin (pBBR1) ([@bib2]), and the *rha*R*-rha*S P~Rha~ promoter ([@bib17], [@bib18]) was used for inducible expression of the recombination operons.

To compare the recombineering efficiency of different systems in one species, all the electroporation was carried out using competent cells prepared from a 1.3 mL fresh culture that are adjusted to the same cell density. After electroporation, 1 mL Luria-Bertani (LB) medium was added for recovery. The data presented are exactly the result from one electroporation, and this methodology was utilized in our previous study ([@bib21], [@bib67]).

We used an assay based on the integration of a PCR product containing gentamycin resistance gene flanked by 100 bp homology arms into the pBBR1 expression plasmid to obtain the plasmid product, pBBR1-Kan-Genta ([Figure 3](#fig3){ref-type="fig"}A). Results are based on counting gentamycin-resistant colonies followed by verification of pBBR1-Kan-Genta by restriction analysis.Figure 3Recombineering with Different Protein Combinations in Different *Pseudomonas* Species(A) Diagram of the recombineering assay. A PCR product carrying a gentamycin resistance gene (Genta) flanked by 100-bp homology arms (thick lines) was integrated into the expression plasmid in place of the artificial operon of the recombination system.(B) Results from the recombineering assay in *P*. *fluorescens* upon the expression of Pluγβα, Redγβα, TE~Psy~, PluγTE~Psy~, RedγTE~Psy~, BAS, PluγBAS, and RedγBAS at 30°C.(C) Results from *P*. *syringae*, which was set up as described in (B).(D) Results from *P*. *putida*, which was set up as described in (B), with the exception that RedγTE~Psy~ was missing owing to the failure of transformation.(E) Results from *P*. *aeruginosa* at 30°C, which was set up as described in (B), and the correct rates are indicated at the top of each column.(F) Results from *P*. *aeruginosa* at 30°C, which was calculated from the correct rates of (E), and the y axis represents the number of correct colony.(G and H) (G) and (H) are as in (E) and (F), respectively, except the proteins were expressed at 37°C. Colonies were selected on gentamycin plates and counted.Data represent the mean ± SD from three independent experiments. The statistical analysis used is Student\'s t test. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.

*P*. *fluorescens*, *P*. *syringae, and P*. *putida* were grown and tested at 30°C ([Figures 3](#fig3){ref-type="fig"}B--3D). Eight recombinants of pBBR1-Kan-Genta were verified by restriction analysis and found to be 100% in all three strains. Expression of Pluγ and Redγ enhanced recombination in *P*. *fluorescens* but appeared to impair it in *P*. *putida* possibly because the expression of Pluγ or Redγ had a toxic effect. Indeed, we could not cultivate *P*. *putida* carrying the RedγTE~Psy~ expression plasmid. In all three strains, both TE~Psy~ and BAS systems worked better than Redγβα and Pluγβα.

A different outcome was observed in *P*. *aeruginosa* where the acquisition of gentamycin resistance, possibly due to intrinsic multidrug resistance mechanisms ([@bib50]), did not faithfully reflect recombination into pBBR1. Consequently, both gentamycin-resistant colonies and the correct recombination rates are presented in [Figures 3](#fig3){ref-type="fig"}E--3H. Because *P*. *aeruginosa* normally grows at 37°C, we tested recombination at both 30°C and 37°C. At 30°C, Pluγ significantly increased the efficiency of both the TE~Psy~ and BAS systems, but it failed to have an effect at 37°C indicating thermolability. In contrast, Redγ increased the efficiency of BAS at both 30°C and 37°C. As with the other three strains, the PluγTE~Psy~, PluγBAS, and RedγBAS systems were superior to Redγβα and Pluγβα. Notably, the correct ratio of PluγTE~Psy~ at 30°C was 92%, which was the most efficient of all variations tested in *P*. *aeruginosa*. However, PluγTE~Psy~ showed no activity at 37°C and RedγBAS presented the best performance ([Figures 3](#fig3){ref-type="fig"}E--3H). We suggest that Pluγ and TE~Psy~ are inactive above 30°C and Redγ and BAS are active at 37°C. These temperature optima concord with the origins of these proteins.

Functional Dissection of BAS {#sec2.4}
----------------------------

Based on the above evaluation, the BAS system, with or without Redγ, can be used for genome engineering in various *Pseudomonas* strains. Because the single-stranded DNA-binding protein S is the unusual aspect of this operon, we further investigated its contribution to recombineering first in *E*. *coli* where neither BA nor BAS functioned well without Redγ. However, in the presence of Redγ, S promoted recombineering efficiency about 4-fold ([Figure 4](#fig4){ref-type="fig"}A). A similar effect was found in *P*. *aeruginosa* ([Figure 4](#fig4){ref-type="fig"}B), whereas in *P*. *syringae*, Redγ stimulated recombination in the absence of S but impaired it in its presence ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Functional Analysis of SSB(A--C) Results from the recombineering assay in [Figure 3](#fig3){ref-type="fig"}A in *E*. *coli,* (A), *P*. *aeruginosa* (B), and *P*. *syringae* (C) upon expression of BA or RedγBA in the presence and absence of SSB. Colonies were selected on gentamycin plates and counted.(D) Results from LCHR assay in *E*. *coli* upon expression of RedγBA or RecET-Redγ in the presence and absence of SSB.(E) As in (D) except using LCHR assay.(F) Efficiency of LLHR mediated by ETg, ETgSSB~phage_Ab31~, ETgSSB~*E_coli*~, and ETgSSB~F_plasmid~. Colonies were selected on chloramphenicol or kanamycin plates and counted.Data represent the mean ± SD from three independent experiments. The statistical analysis used is Student\'s t test. \*p \< 0.05, \*\*p \< 0.001, \*\*\*p \< 0.0001.

To further investigate the effect of S, we evaluated its effect of Red- and RecET-mediated recombination, which differ mechanistically. Redγβα requires a replicating substrate and acts at the replication fork ([@bib33]), whereas full-length RecE/RecT recombines two linear DNAs before replication ([@bib21]). We term these two mechanisms linear plus circular homologous recombination (LCHR) and linear plus linear homologous recombination (LLHR). Addition of S to Red LCHR has a small positive effect, whereas it substantially enhances RecET LCHR ([Figure 4](#fig4){ref-type="fig"}D). Conversely, S does not convey LLHR capacity onto Red but substantially enhances RecET LLHR ([Figure 4](#fig4){ref-type="fig"}E). Consequently, we tried two more SSBs, which are from *E*. *coli* and F plasmid, and both also enhanced RecET LLHR ([Figure 4](#fig4){ref-type="fig"}F).

Optimization of Recombineering in *Pseudomonas* {#sec2.5}
-----------------------------------------------

After identifying the optimal recombineering configurations for each *Pseudomonas* strain, i.e., PluγTE~Psy~ for *P*. *aeruginosa* at 30°C, RedγBAS for *P*. *aeruginosa* at 37°C, BAS for *P*. *putida* and *P*. *syringae*, and RedγTE~Psy~ or RedγBAS for *P*. *fluorescens*, we further optimized the protocols. Apart from electrocompetent cell preparation, the amount of DNA to be transformed and the length of its homology arm to the target play large roles in determining efficiency ([@bib21], [@bib67]). We titrated the DNA amount from 100 ng to 2 μg. It was observed that 1 μg DNA was sufficient for *P*. *fluorescens*, *P*. *syringae,* and *P*. *putida* ([Figures S3](#mmc1){ref-type="supplementary-material"}A, S3C, and S3E). However, *P*. *aeruginosa* required 1.5 μg of DNA to achieve a decent efficiency ([Figure S3](#mmc1){ref-type="supplementary-material"}G). For all three strains, the saturation amount of DNA was 1.5 μg. The length of the homology arm was tested across a range from 30 to 150 bp. One hundred base pairs were sufficient for *P*. *fluorescens* ([Figure S3](#mmc1){ref-type="supplementary-material"}B) and *P*. *putida* ([Figure S3](#mmc1){ref-type="supplementary-material"}F). *P*. *syringae* ([Figure S3](#mmc1){ref-type="supplementary-material"}D) and *P*. *aeruginosa* ([Figure S3](#mmc1){ref-type="supplementary-material"}H) required 120 bp for significantly higher efficiency. Although a 150-bp homology arm further boosted the efficiency for *P*. *aeruginosa*, we did not employ this advantage owing to cost and concerns over the quality of long oligonucleotide syntheses.

Recombineering *Pseudomonas* Genomes {#sec2.6}
------------------------------------

To validate the methods, we designed several genome engineering exercises beginning with the construction of an attenuated *P*. *aeruginosa* PAO1 mutant. *P*. *aeruginosa* produces a number of virulence factors, including exotoxin A ([@bib35]), pyocyanin ([@bib66]), elastase ([@bib36]), and periplasmic glucans ([@bib32]), which prevent the safe use of this strain for the production of rhamnolipids. As diagrammed in [Figure 5](#fig5){ref-type="fig"}A, a number of gene knockouts were performed by electroporating a PCR product containing a gentamycin resistance gene flanked by lox71/lox66 sites and 75-bp homology arms. The *aro*A gene (1917 bp) encodes 3-phosphoshikimate 1-carboxyvinyltransferase, which is essential for the synthesis of aromatic amino acids. Deletion of *aro*A can completely prevent *P*. *aeruginosa* infection of mammalian cells ([@bib46]). The *phn*AB (2172bp) gene is involved in pyocyanin biosynthesis ([@bib29]). The *las*B gene (1497 bp) encodes elastase ([@bib36]). The *mdo*H gene (2586 bp) is required for the biosynthesis of periplasmic glucans ([@bib32]). To knock out these genes, each electroporation yielded approximately 100 gentamycin-resistant colonies when PluγTE~Psy~ was expressed, and all the clones were correct. We also used the RedγBAS system and noticed approximately 1000 small and 100 large gentamycin-resistant colonies, but only about half of the large colonies were correct according to colony PCR ([Figures 5](#fig5){ref-type="fig"}B, 5D, 5F, and 5H). To generate a selectable marker-free *P*. *aeruginosa* PAO1 mutant, Cre catalyzed the excision of the lox-flanked DNA ([Figures 5](#fig5){ref-type="fig"}C, 5E, 5G, and 5I).Figure 5PCR Verification of the Genome Engineering of *P*. *aeruginosa* by Recombineering through RedγBAS System at 37°C(A) Diagram of the genome engineering of *P*. *aeruginosa* and schematic presentation of the PCR setup for verification.(B) *aro*A gene knockout via replacement with a gentamycin selection marker. Lane C is the wild-type strain, used as a negative control. Lane M is the Takara DL5000 marker. Lanes 1 and 2 are recombinants. Both clones 1 and 2 are correct.(C) Gentamycin selection marker deletion via Cre recombination for *aro*A gene knockout. Both clones 1 and 2 are correct.(D) *phn*AB gene knockout via replacement with a gentamycin selection marker. Both clones 1 and 2 are correct.(E) Gentamycin selection marker deletion via Cre recombination for *phn*AB gene knockout. Six clones are correct.(F) *las*B gene knockout via replacement with a gentamycin selection marker. Both clones 1 and 2 are correct.(G) Gentamycin selection marker deletion via Cre recombination after *las*B gene knockout. Both clones are correct.(H) *mdo*H gene knockout via replacement with a gentamycin selection marker. The tested clone is correct.(I) Gentamycin selection marker deletion via Cre recombination after *mdo*H gene knockout. Four clones are correct.

*Pseudomonas* exotoxin A is a single-chain toxin with three structural domains that inhibit protein synthesis in eukaryotic cells by catalyzing ADP ribosylation of elongation factor 2. The amino-terminal domain I is involved in eukaryotic cell recognition ([@bib26]), the central domain II may be involved in the translocation function of the protein ([@bib52]), and the carboxy-terminal domain III has a cleft that is proposed to be the enzyme active site ([@bib8]). Glu-578 in domain III has been identified as an active site residue for nicotinamide adenine dinucleotide binding ([@bib8]). To evaluate the ability of the recombineering system to achieve a seamless mutation, we aimed to mutate this residue. A single-nucleotide substitution of ToxA (GAG Glu-578 codon to GAC Asp) was achieved by two rounds of recombineering ([Figure S4](#mmc1){ref-type="supplementary-material"}A). First, a PCR product with a gentamycin resistance and counter-selection (SacB) genes flanked by 75-bp homology arms was introduced into *P*. *aeruginosa* expressing PluγTE~Psy~. After the gentamycin-resistant clones were verified by colony PCR ([Figure S4](#mmc1){ref-type="supplementary-material"}B), SacB function was tested ([Figure S5](#mmc1){ref-type="supplementary-material"}). In the second round of recombineering, a point mutation (GAG Glu-578 codon to GAC Asp) was introduced using 121-bp oligonucleotide with 60-bp homology arms either side of the point mutation. The reaction was mediated by PluγTE~Psy~, and the mutant strain was screened on LB plates containing 10% sucrose. Successful site-directed mutagenesis was confirmed by colony PCR ([Figure S4](#mmc1){ref-type="supplementary-material"}C) and sequencing ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

The BAS system was also successfully applied to genome engineering of *P*. *syringae* pv. tomato str. DC3000 by placing a promoter (P~genta~) in front of a silent gene cluster for a secondary metabolite pathway. Insertion of the promoter was efficient. Each electroporation yielded about 120 gentamicin-resistant colonies. Three colonies were verified by colony PCR ([Figure S6](#mmc1){ref-type="supplementary-material"}A), and all of them were correct. However, we could not detect any new compound produced by the engineered strain (data not shown). We also engineered the *P*. *fluorescens* genome with the RedγTE~Psy~ system. The *ret*S gene of *P*. *fluorescens* was knocked out, and the mutant strain was confirmed by colony PCR ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Each electroporation yielded approximately 20 gentamicin-resistant colonies, and all of them were correct. The hybrid sensor kinase (RetS) negatively controls the production of antibiotics, including 2,4-diacetylphloroglucinol, pyrrolnitrin, and pyoluteorin, in *P*. *fluorescens* ([@bib69]). Genetic inactivation of *ret*S results in enhanced biocontrol capacity of the strain ([@bib69]).

Using the Attenuated *P*. *aeruginosa* PAO1 Mutant for Rhamnolipid Production {#sec2.7}
-----------------------------------------------------------------------------

Although much effort has been invested in heterologous expression of *rhl*AB, the pathogenic strain *P*. *aeruginosa* PAO1 remains the best producer of rhamnolipids ([@bib72]). To evaluate the safety of an attenuated *P*. *aeruginosa* PAO1 strain, we examined their virulence in mice and *C*. *elegans* models. The 50% lethal dose for wild-type PAO1 given by intraperitoneal (i.p.) injection was 4 × 10^8^ colony-forming unit (CFU). However, no toxic effects were observed with i.p. doses of the attenuated mutant PAO1aroA up to 1 × 10^9^ CFU ([Figure 6](#fig6){ref-type="fig"}A). In contrast, the PABMT mutant (*phn*AB^−^, *las*B^−^, *mdo*H^−^, and *tox*A^−^) was still pathogenic to BALB/c mice ([Table S7](#mmc1){ref-type="supplementary-material"}) and postponed the egg stage in *C*. *elegans* ([Figure S7](#mmc1){ref-type="supplementary-material"}).Figure 6Overexpression of *rhl*AB and *est*A in the PAO1 Mutant for Rhamnolipid Production(A) The survival rate of BALB/c mice after intraperitoneal injection of wild-type PAO1 and the PAO1*aro*A mutant strain (1\*10^9^ CFU).(B) Rhamnolipid production in wild-type PAO1 and the PAO1*aro*A mutant from a 2-day fermentation. The statistical analysis used is Student\'s t test. \*p \< 0.05, \*\*p \< 0.01.(C) Emulsification activity of cell culture supernatants. Equal parts of toluene and supernatant were combined in a glass vial, vortexed vigorously, and rested for 2 h.(D) Plasmid stability in the PAO1aroA mutant. The tested plasmid was pBBRI-estA-genta-rhlAB. This strain was cultured in Murashige and Skoog (MS) medium supplemented with aromatic amino acids without antibiotic, and the number of cells was counted on LB plates with and without gentamycin every day. The ratio of gentamycin-resistant clones to total cells was calculated. Data represent the mean ± SD from three independent experiments.

The PAO1*aro*A mutant is auxotrophic for aromatic amino acids and must be cultivated with aromatic amino acid supplement. Under these conditions, the wild-type PAO1 strain entered log phase in 2 h, but the PAO1*aro*A mutant strain grew more slowly, entering log phase in 5 h ([Figure S8](#mmc1){ref-type="supplementary-material"}). Nevertheless, when we compared rhamnolipid production after 48 h of fermentation, there was no significant difference between the wild-type PAO1 and PAO1*aro*A mutant strains ([Figure 6](#fig6){ref-type="fig"}B).

To increase rhamnolipid production in the PAO1*aro*A mutant, we introduced a plasmid carrying *rhl*AB, which participates in the biosynthesis of this biosurfactant ([@bib42]), and the *est*A gene, which encodes an autotransporter protein located in the outer membrane ([@bib62]) ([Figure S9](#mmc1){ref-type="supplementary-material"}). Overexpression of *rhl*AB and *est*A in wild-type PAO1 and the PAO1*aro*A mutant increased the yield of rhamnolipids ([Figure 6](#fig6){ref-type="fig"}B). Using a toluene emulsion assay ([@bib6]), we tested the emulsive potential of the PAO1*aro*A mutant in the presence of *rhl*AB and *est*A. Visible emulsions formed in the supernatants of both wild-type PAO1 and the PAO1*aro*A mutant ([Figure 6](#fig6){ref-type="fig"}C). We also confirmed the stability of the expression plasmid pBBR1-estA-genta-rhlAB, which replicated in the PAO1*aro*A mutant without antibiotic selection ([Figure 6](#fig6){ref-type="fig"}D). Thus a safe rhamnolipid producer for industrial fermentation has been established.

Discussion {#sec3}
==========

Although the Red system has been applied to engineer the genome of *E*. *coli* and a number of genetically close species, apparent host-specific factors limit its wider application ([@bib67]). Consequently, we and others have searched for other phage exonuclease/SSAP pairs associated with genetically distant bacterium. This includes the prophage RecET~Psy~ system, which has been used in *P*. *syringae* so far ([@bib56]).

Several attempts of recombineering in *P*. *putida* have been recently reported. However, the enzymes are *lambda* Red ([@bib9], [@bib11], [@bib31]) and *rac* RecET ([@bib10]), or an SSAP without an accompanying exonuclease ([@bib4], [@bib3], [@bib47]). It is well known that the use of SSAPs alone is only effective with single-stranded oligonucleotides and will not mediate the dsDNA homologous recombination events.

*Pseudomonas* is a large genus including *P*. *aeruginosa*, *P*. *chlororaphis*, *P*. *fluorescens*, *P*. *pertucinogena*, *P*. *putida*, *P*. *stutzeri*, *P*. *syringae,* and a large number of *Incertae sedis*. In a search for recombineering solutions to cover this broad range, we worked with representatives from four groups, namely, *P*. *aeruginosa*, *P*. *fluorescens*, *P*. *putida,* and *P*. *syringae*. In addition to RecET~Psy~, we identified another operon in the *Pseudomonas* phage vB_PaeP_Tr60_Ab31 ([@bib28]) ([Figure 1](#fig1){ref-type="fig"}). These operons differ from the *E*. *coli* lambda Red operon (Redγβα) or our previously reported *P. luminescens* operon (Pluγβα) ([@bib67]) because they do not appear to include a Redγ/Pluγ-type inhibitor of the major host exonuclease RecBCD, which protects linear dsDNA ends from degradation and thereby facilitates recombination. Therefore we added Pluγ and Redγ to the TE~Psy~ and BAS systems to evaluate their impact on recombineering. Owing to apparent toxicity and temperature optima, we did not arrive at a single optimal configuration for all four *Pseudomonas* species. In *P*. *aeruginosa* PluγTE~Psy~ delivered the best results at 30°C, whereas RedγBAS was the configuration for 37°C. Furthermore, Redγ and Pluγ increased recombineering efficiency in *P*. *aeruginosa* and *P*. *fluorescens,* but Redγ was deleterious in *P*. *putida* and *P*. *syringae*. We suggest that Redγ likely alters the function of the RecBCD complex in *E*. *coli*, *P*. *aeruginosa,* and *P*. *fluorescens* in the same manner by temporarily blocking its exonuclease activity. However, the interaction between Redγ and RecBCD in *P*. *syringae* or *P*. *putida* might proceed differently, potentially to have an effect on RecBCD-mediated genome repair.

Consequently, after evaluating different configurations in four *Pseudomonas* species, we found that the BAS system was functional in all four tested *Pseudomonas* strains and so has the potential to be a generic system for *Pseudomonas* after testing for Pluγ or Redγ functionality.

We report the usefulness of an SSB in a recombineering system. The three-element BAS and four-element hybrid RedγBAS systems are useful genome engineering tools in certain *Pseudomonas* strains. Consequently, we were motivated to explore the utility of S, the phage Ab31 SSB, in both established recombineering paradigms, Red and RecET in LCHR and LLHR applications.

In *E*. *coli*, S clearly contributed to BA recombination. Addition of S had little impact on Red recombination. However, it substantially enhanced RecET in both LCHR and LLHR assays ([Figures 4](#fig4){ref-type="fig"}D and 4E).

SSBs play crucial roles in DNA replication, recombination, DNA damage signaling, and repair in all organisms ([@bib65]). In addition, SSBs can protect ssDNA from further degradation after 5′-3′ exonuclease resection ([@bib37]). SSB also forms a protein interaction platform by recruiting DNA replication and recombination enzymes, such as exonuclease I ([@bib30]) and RecJ ([@bib24]). Biochemical studies of different recombination systems have revealed that SSB binds to and removes secondary structures from ssDNA during the presynapsis stage ([@bib27]), which facilitates homologous strand pairing. Therefore, an SSB could potentially contribute to recombineering in three ways, namely, protection of ssDNAs involved in recombination from degradation, interaction(s) with the recombination machinery, or removal of secondary structures in ssDNA intermediates. We designed an experiment to test this third possibility to determine if homologous recombination efficiency was affected by secondary structure of the homology arm and whether an SSB could ameliorate the impact. However, on comparison of a homology arm with notable secondary structure to an arm with moderate secondary structure, there was no bias with or without SSB overexpression in the recombineering host ([Figures 7](#fig7){ref-type="fig"}A--7C). Although further studies are necessary to elucidate the biological role of SSB in recombineering, we suggest that the variable contributions of a RecBCD inhibitor or an SSB in different contexts reflect different recombination susceptibilities to double- or single-stranded exonucleases.Figure 7Effects of Secondary Structure on Recombineering with or without SSB(A) Secondary structure predictions of the standard homology arm (HA-STD) and tested homology arms (HA-A, HA-B, and HA-D) from the RNAfold Webserver (<http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi>) ([@bib34]).(B) Diagram of the LLHR assay in *E*. *coli* ([@bib21]). Each end of the kan-PCR product has a 50-bp homology arm to the p15A-cm PCR product between the chloramphenicol gene (cm) and the p15A origin (indicated by red and green arrows).(C) Results from the LLHR assay depicted in (B) upon expression of full-length RecE, RecT, and Redγ with or without SSB. Colonies were selected on kanamycin or chloramphenicol plates and counted.Data represent the mean ± SD from three independent experiments. The statistical analysis used is Student\'s t test. \*p \< 0.05, ns: not significant.

Based on the RedγBAS and PluγTE~Psy~ recombineering systems, we constructed two *P*. *aeruginosa* mutants, PABMT and PAO1*aro*A. PABMT could postpone the egg stage for *C*. *elegans* but was still pathogenic to BALB/c mice, suggesting the presence of additional pathogenic factors. PAO1*aro*A is a highly attenuated strain ([Figure 6](#fig6){ref-type="fig"}A) with potential for several applications, such as live vaccines ([@bib46]). In the present study, the highly attenuated mutant was used to produce rhamnolipid biosurfactants. Rhamnolipids are surface-active secondary metabolites produced by *P*. *aeruginosa* or related species in the stationary phase ([@bib68]). In the last decade, these molecules have emerged as a promising class of biosurfactants for several applications, such as moisturizers, lubricants, and shampoos ([@bib14]). Rhamnolipids are also effective in the bioremediation of organic and heavy-metal-polluted sites. Consequently, various efforts, including heterologous expression of *rhl*AB, have been made to establish high-yield rhamnolipid-producing strains. However, *P*. *aeruginosa* remains the best rhamnolipid producer. Based on the attenuated strain, further modifications to increase secondary metabolite production would involve the overexpression of proteins that participate in biosynthetic and/or regulatory pathways ([@bib14]). As expected, the overexpression of *rhl*AB and *est*A in wild-type PAO1 and the PAO1*aro*A mutant strain increased the yield of rhamnolipids ([Figure 6](#fig6){ref-type="fig"}B). The rhamnosyltransferase 1 complex (RhlAB) is the key enzyme responsible for transferring the rhamnose moiety to the β-hydroxyalkanoic acid moiety during rhamnolipid biosynthesis ([@bib61]). Rhamnolipid production in *P*. *aeruginosa* is regulated by the hierarchical quorum-sensing systems (LasI/R and RhlI/R systems) ([@bib53]). EstA indirectly influences the synthesis of quorum-sensing molecules by providing the cells with fatty acids ([@bib48]).

For *P*. *aeruginosa* PAO1, after electroporation the recombinants were selected on LB agar plates supplemented with gentamycin (15 μg/mL). There were false-positive colonies, which were smaller. According to colony PCR using the internal primer pairs binding to the gentamycin resistance gene, this was not random integration of the cassette ([Figure S10](#mmc1){ref-type="supplementary-material"}). As negative controls we observed that there were gentamycin-resistant colonies of *P*. *aeruginosa* after electroporation without adding DNA. Most likely the intrinsic multidrug resistance mechanisms of *P*. *aeruginosa* were enhanced after electroporation as a stress response. However these false-positive colonies were not problematic for screening, as they did not grow in liquid LB containing gentamycin (15 μg/mL) because of antibiotic selection being more stringent in the liquid medium than in the solid medium (data not shown).

Here, we developed recombineering systems for *Pseudomonas* for several reasons including circumventing the inconvenience of constructing a suicide plasmid with long homology arms for genome engineering, which then requires tedious PCR screening of single-crossover and double-crossover events ([@bib25]). Further work to construct efficient recombineering systems for more distantly related gram-negative bacteria may require not only the identification of new Red-like or RecET-like operons but also testing combinations of SSBs and Redγ-like proteins with the phage exonuclease/SSAP pairs.

Limitations of the Study {#sec3.1}
------------------------

We evaluated two *Pseudomonas* endogenous phage recombinant systems (BAS and RecET~psy~) in various strains and use the *E*. *coli* Red and Plu Red recombinant proteins (Redγβα and Pluγβα) as references. These proteins were expressed using the same inducible promoter and the same plasmid origin. However, we did not assess the expression levels of such proteins, so future experiments are needed to test whether differences in expression levels of these proteins can explain different recombineering efficiencies among strains.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S10, and Tables S1--S7
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